Filing Overview
This Form 8-K was filed by TradeUP Acquisition Corp., not Estrella Immunopharma, Inc. The report was filed October 11, 2022, for an event occurring October 10, 2022. TradeUP is a special purpose acquisition company incorporated in January 2021 and listed on Nasdaq under UPTDU, UPTD, and UPTDW.
Material Event
Under Item 4.01, the company disclosed a change in its independent registered public accounting firm. Friedman LLP continued to serve as auditor through October 10, 2022. Following Friedman's combination with Marcum LLP, the Board and Audit Committee approved Friedman's dismissal and the engagement of Marcum LLP, effective October 10, 2022, for the fiscal year ending December 31, 2022.
Financial Metrics and Liquidity
The filing does not provide current revenue, earnings, cash flow, margins, debt, liquidity, or other operating financial metrics. It is limited primarily to the auditor transition.
Prior-Period Comparisons
- Friedman audited the company's financial statements for the year ended December 31, 2021.
- Friedman's 2021 audit report contained no adverse opinion or disclaimer and was not qualified or modified regarding uncertainty, audit scope, or accounting principles.
- The company reported no disagreements with Friedman regarding accounting principles, financial statement disclosures, or audit scope or procedures during 2021 or the subsequent interim period through October 10, 2022.
- The company also reported no reportable events during that period.
Guidance, Risks, and Unusual Items
No financial guidance or operating outlook was provided. The auditor change resulted from Friedman's combination with Marcum rather than a reported disagreement or reportable event. The company stated that neither it nor anyone acting on its behalf had consulted Marcum before the engagement regarding accounting principles, audit opinions, disagreements, or reportable events.
Investor Verification Items
- Confirm that the filing pertains to TradeUP Acquisition Corp. rather than Estrella Immunopharma, Inc.
- Review Exhibit 16.1, Friedman's October 11, 2022 letter regarding the auditor transition.
- Verify Marcum's appointment for the fiscal year ending December 31, 2022 and review subsequent filings for any audit qualification, going-concern disclosure, or additional auditor changes.
- Obtain the company's annual and subsequent periodic reports for financial performance, trust-account balances, liquidity, merger activity, and redemption or extension developments, none of which are addressed in this filing.